| http://www.w3.org/ns/prov#value | - GERD sufferers can manifest itself as symptoms such as heartburn and regurgitation.More than 50 per cent of all diabetics suffer from gastroparesis, or more than 85 million people worldwide.Gastroparesis can lead to severe symptoms such as pain, nausea and vomiting, and even malnutrition.ATI-7505 is not the first serotonin type 4 (5HT4) agonist to hit the market for gastrointestinal disorders.
|
